Bactericidal activity of oxacillin and glycopeptides against Staphylococcus aureus in patients with endocarditis: Looking for a relationship between tolerance and outcome
2011

Bactericidal Activity of Antibiotics Against Staphylococcus aureus in Endocarditis

Sample size: 62 publication Evidence: moderate

Author Information

Author(s): Pasticci Maria Bruna, Moretti Amedeo, Stagni Giuliano, Ravasio Veronica, Soavi Laura, Raglio Annibale, Vailati Francesca, Cardaccia Angela, Santucci Antonella, Papili Rita, Sgrelli Alessio, Pallotto Carlo, Baldelli Franco

Primary Institution: University of Perugia

Hypothesis

Is there a relationship between in vitro bactericidal activity and clinical outcome in patients with endocarditis?

Conclusion

In vitro bactericidal test results were not valid predictors of clinical outcome.

Supporting Evidence

  • Overall, 72.6% of patients were cured.
  • Tolerance to oxacillin was more common than tolerance to vancomycin.
  • 32.3% of patients required surgery.
  • Embolic events were documented in 64.5% of cases.

Takeaway

Doctors studied how well certain antibiotics kill a germ called Staphylococcus aureus in patients with heart infections, but found that lab tests didn't always match how patients did in real life.

Methodology

The study involved determining minimal bacteriostatic and bactericidal concentrations for Staphylococcus aureus strains and reviewing medical records for patient data.

Potential Biases

Potential bias due to retrospective data collection and non-standardized treatment protocols.

Limitations

The study was retrospective and treatment was not standardized.

Participant Demographics

62 patients with endocarditis, 58% male, 91.9% definite cases, 75.8% native valve endocarditis.

Statistical Information

P-Value

p<0.032

Statistical Significance

p<0.032

Digital Object Identifier (DOI)

10.1186/1476-0711-10-26

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication